SkinHealth Systems — Third Quarter 2026 Earnings Summary

SkinHealth Systems reported third-quarter 2026 net sales of $69.2 million, a 2.1% decrease from the prior year period, driven by lower delivery system sales. The company achieved a gross margin of 68.2% and an adjusted EBITDA of $13.4 million, reflecting improved operational efficiency and cost discipline. Net loss for the quarter narrowed to $0.9 million compared to $11.0 million in the same period last year, while the company retired $103.2 million in outstanding debt. Updated full-year 2026 guidance projects net sales between $281 million and $287 million and adjusted EBITDA between $48 million and $50 million.